Prohost BiotechResearch Platform

Home Articles Categories Tags Subscribe

Loading articles...

Prohost BiotechResearch Platform

Advancing biotechnology through cutting-edge research, innovation, and scientific collaboration.

Platform

Articles Categories Tags

Resources

About Us FAQ Contact Privacy Policy Terms & Conditions Cookie Policy

© 2026 Prohost Biotech. All rights reserved. Prohost Biotech is a registered trademark of Prohost Biotech.

Prohost BiotechResearch Platform

Home Articles Categories Tags Subscribe

Tag

#Atossa Genetics (ATOS)

2 articles found with this tag

Showing 1 to 2 of 2 articles

Today's Highlights

Atossa Genetics Has Promising News

Atossa Genetics Promising News for Endoxifen Atossa Genetics ( ATOS ) has promising news from a Phase 2 trial of its topical Endoxifen for mammographic breast density ( MBD ) reduction. Prelimin...

Prohost Biotech

Jun 27, 2019

News & Comments

Atossa Genetics' news that staged a huge Rally of this small firm's stock

Atossa Genetics (ATOS) announced that the FDA has issued a “Safe to Proceed” letter under their “expanded access” program permitting the use of Atossa’s oral Endoxifen as a post-mastectomy treatment i...

Prohost Biotech

Mar 14, 2019

Prohost BiotechResearch Platform

Advancing biotechnology through cutting-edge research, innovation, and scientific collaboration.

Platform

Articles Categories Tags

Resources

About Us FAQ Contact Privacy Policy Terms & Conditions Cookie Policy

© 2026 Prohost Biotech. All rights reserved. Prohost Biotech is a registered trademark of Prohost Biotech.